» Articles » PMID: 38472048

VEGF Expression Disparities in Brainstem Motor Neurons of the SOD1 ALS Model: Correlations with Neuronal Vulnerability

Overview
Specialty Neurology
Date 2024 Mar 12
PMID 38472048
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease characterized by severe muscle weakness mainly due to degeneration and death of motor neurons. A peculiarity of the neurodegenerative processes is the variable susceptibility among distinct neuronal populations, exemplified by the contrasting resilience of motor neurons innervating the ocular motor system and the more vulnerable facial and hypoglossal motor neurons. The crucial role of vascular endothelial growth factor (VEGF) as a neuroprotective factor in the nervous system is well-established since a deficit of VEGF has been related to motoneuronal degeneration. In this study, we investigated the survival of ocular, facial, and hypoglossal motor neurons utilizing the murine SOD1 ALS model at various stages of the disease. Our primary objective was to determine whether the survival of the different brainstem motor neurons was linked to disparate VEGF expression levels in resilient and susceptible motor neurons throughout neurodegeneration. Our findings revealed a selective loss of motor neurons exclusively within the vulnerable nuclei. Furthermore, a significantly higher level of VEGF was detected in the more resistant motor neurons, the extraocular ones. We also examined whether TDP-43 dynamics in the brainstem motor neuron of SOD mice was altered. Our data suggests that the increased VEGF levels observed in extraocular motor neurons may potentially underlie their resistance during the neurodegenerative processes in ALS in a TDP-43-independent manner. Our work might help to better understand the underlying mechanisms of selective vulnerability of motor neurons in ALS.

Citing Articles

Tongue exercise ameliorates structural and functional upper airway deficits in a rodent model of hypoglossal motor neuron loss.

Keilholz A, Pathak I, Smith C, Osman K, Smith L, Oti G Front Neurol. 2024; 15:1441529.

PMID: 39296960 PMC: 11408480. DOI: 10.3389/fneur.2024.1441529.

References
1.
Lu L, Zheng L, Viera L, Suswam E, Li Y, Li X . Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci. 2007; 27(30):7929-38. PMC: 6672720. DOI: 10.1523/JNEUROSCI.1877-07.2007. View

2.
Ohgomori T, Yamasaki R, Takeuchi H, Kadomatsu K, Kira J, Jinno S . Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2017; 46(4):2001-2014. DOI: 10.1111/ejn.13650. View

3.
Highley J, Kirby J, Jansweijer J, Webb P, Hewamadduma C, Heath P . Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol Appl Neurobiol. 2014; 40(6):670-85. DOI: 10.1111/nan.12148. View

4.
Silva-Hucha S, Carrero-Rojas G, Fernandez de Sevilla M, Benitez-Temino B, Davis-Lopez de Carrizosa M, Pastor A . Sources and lesion-induced changes of VEGF expression in brainstem motoneurons. Brain Struct Funct. 2020; 225(3):1033-1053. DOI: 10.1007/s00429-020-02057-y. View

5.
Mizuno Y, Fujita Y, Takatama M, Okamoto K . Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders. J Neurol Sci. 2012; 315(1-2):20-5. DOI: 10.1016/j.jns.2011.12.012. View